IPO
LPs see decoupling as bigger issue than delisting - AVCJ Forum
The long-term implications of US-China decoupling are of greater concern than the prospect of Chinese companies being forced to delist from US stock exchanges, LPs told the AVCJ China Forum.
Bain's Asia data center platform seeks US listing
Chindata Group Holdings, which claims to be the largest player in emerging markets Asia’s carrier-neutral hyperscale data center industry in terms of capacity in service, has filed for an IPO.
Ex-L Catterton Asia head Ravi Thakran launches SPAC
Ravi Thakran, formerly head of L Catterton’s Asia operation, has launched a US-listed special purpose acquisition company (SPAC) to pursue aspirational consumer brands.
Macro, geopolitical concerns not deterring China exits
Private equity investors are seeing significant IPO and exit activity out of China despite macroeconomic and geopolitical uncertainty arising from COVID-19 and China-US tensions, respectively.
China's Xpeng raises $1.5b in US IPO, soars on debut
Chinese electric vehicle manufacturer Xpeng – which has a string of PE and VC investors – gained 41% on its New York trading debut after raising $1.5 billion in an upsized IPO.
PE-backed Kalyan Jewellers files for $235m IPO
Indian jewelry retailer Kalyan Jewellers, which counts Warburg Pincus among its investors, is looking to raise INR17.5 billion ($235.7 million) through a domestic IPO.
PE-backed Ant Group files for Hong Kong, Shanghai IPO
Ant Group, the financial technology affiliate of China’s Alibaba Group, which has raised more than $20 billion in external private funding, has filed for a dual listing in Hong Kong and Shanghai.
China expands registration-based IPO system to ChiNext
Registration-based IPOs - which rely on information disclosures rather than regulatory approvals - have arrived on Shenzhen's ChiNext board following a successful trial on the Shanghai Star Market.
China's VC-backed CanSino raises $748m in Star Market IPO
Chinese vaccine developer CanSino Biologics, which counts Lily Asia Ventures (LAV) and Qiming Venture Partners among its investors, has raised RMB5.2 billion ($748 million) in an IPO on Shanghai’s Star Market.
Chinese EV manufacturer Xpeng pursues US IPO
Xpeng Motors, a Chinese electric vehicle (EV) manufacturer backed by Alibaba Group and several PE and VC firms, has filed for a US IPO.
China IPOs: Onshore attraction
The valuations available on China's booming Star Market are prompting US dollar managers to consider restructuring companies for onshore listings. How long will the fervor last?
China's Li Auto gains 43% on debut after $1.1b US IPO
Chinese electric vehicle manufacturer Li Auto closed up 43% on its first day of trading on NASDAQ following a $1.1 billion IPO.
Chinese real estate platform Beike pursues US IPO
Beike, a Chinese online real estate platform backed by Tencent Holdings, SoftBank Vision Fund and Hillhouse Capital, has filed for US IPO.
SPACs: Flavor of the month
Special purpose acquisition companies (SPACs) are gaining popularity among private equity investors in Asia. While these structures have various attractive qualities, they aren't for everyone
PE-backed Cambricon becomes China's first listed AI chip maker
Beijing-based Cambricon Technology, which is backed by CICC Capital, Alibaba Group, and Lenovo, has listed on the Star Market. It is the first Chinese artificial intelligence (AI) chip manufacturer to complete an IPO.
Canyon Bridge, K2 Venture founders join Asia SPAC wave
Two more groups featuring Asian private equity executives have listed special purpose acquisition companies (SPACs) on US bourses as interest in these structures continues to rise globally.
PE-backed Junshi Biosciences shines on Star Market debut
PE-backed Junshi Biosciences has become the first Chinese biotech company to list in Hong Kong and the mainland, following a strong debut on Shanghai's Star Market.
2Q analysis: Numbers that deceive
Asia has seen remarkable revivals in private equity investment and fundraising – though not in exits – over the past three months. A handful of large-cap situations mask a weak environment
Ocumension climbs on debut after $184m Hong Kong IPO
Ocumension Therapeutics, a Chinese drug developer targeting eye diseases that counts Boyu Capital and Temasek Holdings among its backers, posted a 152% gain on debut following a HK$1.5 billion ($200 million) Hong Kong IPO.
China EV maker Li Auto pursues US listing
Li Auto, a Chinese electric vehicle manufacturer that has been backed by online-to-offline (O2O) services giant Meituan Dianping, has filed for a US IPO.
Portfolio: CBC Group and I-Mab Biopharma
CBC Group’s stewardship of I-Mab Biopharma brings an intensely hands-on platform-based approach to a booming China biotech space often characterized by relatively passive strategies
China gay dating app Blued raises $85m in US IPO
BlueCity Holdings, the VC-backed holding company for Chinese gay dating platform Blued, traded strongly after raising $84.8 million through a NASDSAQ IPO.
Korea's ACE Equity launches SPAC targeting IT infrastructure
Korean private equity firm ACE Equity Partners has taken another step in the development of its cross-border investment capabilities with the launch of a US-listed special purpose acquisition company (SPAC) to pursue IT infrastructure assets.
China IPOs: Star attraction
Having previously focused on offshore IPOs, China managers with US dollar funds are now considering the Star Market. But going onshore means more regulation as well as high valuations